Hi! Colleagues, I have couple of basic questions on cytoplasmic CD22. Why people are interested in Cytoplasmic CD22 in clinical lab? Why it is not important to differentiate between surface and cytoplasmic CD22? Finally, for B-cell ALL which cell populations I should look into for the cytoplasmic CD22/MPO? Thanks. Qing Li, Ph.D. NTTD Department South Bend Medical Foundation South Bend, IN qli@sbmflab.org ----------
This archive was generated by hypermail 2b29 : Wed Apr 03 2002 - 11:57:54 EST